Incidence of positive surgical margins after robotic assisted radical prostatectomy: Does the surgeon's experience have an influence on all pathological stages? - Abstract

OBJECTIVE: The aim of this study is to analyze the clinical and surgical features of patients who underwent robotic-assisted radical prostatectomy (RARP) at our institution, and the impact of the surgeon's experience in the oncological results related to pathological stage.

MATERIAL AND METHODS: An analysis of 300 RARP consecutively performed by the same urologist was conducted. Patients were divided into 3 groups of 100 patients in chronological order, according to surgery date. All patients had organ-confined clinical stage. Variables which could impact in positive margins rates were analyzed. Finally, positive surgical margins (PSM) in regard to pathological stage and surgeon's experience were compared and analyzed.

RESULTS: No significant differences were found in variables which could impact in PSM rates. The overall PSM rate was 21%, with 28% in the first group, 20% in the second, and 16% in the third (P=.108). Significant lineal decreasing tendency was observed (P=.024). In pT2 patients, the overall PSM rate was 16.6%, with 27%, 13.8%, and 7.3% in each group respectively (P=.009). A significant difference was found between group 1 and group 3 (P=.004). In pT3 patients, the surgeon's experience was not significantly associated with margin reductions with an overall PSM rate of 27.7% (28.2%, 28.6%, and 26.7% in each group respectively).

CONCLUSIONS: Clinical and surgical features in our patients did not vary over time. We found a significant reduction of PSM related to surgeon's experience in pT2 patients. Contrariwise, the margin status remained stable despite increasing experience in pT3 patients.

Written by:
Villamil AW, Costabel JI, Billordo Peres N, Martínez PF, Giudice CR, Damia OH.   Are you the author?
Departamento de Urología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Reference: Actas Urol Esp. 2013 Oct 9. pii: S0210-4806(13)00304-5.
doi: 10.1016/j.acuro.2013.07.011


PubMed Abstract
PMID: 24119633

Article in English, Spanish.

UroToday.com Prostate Cancer Section